• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于晶体结构的酵母分支酸变位酶的催化及别构调节机制

Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.

作者信息

Sträter N, Schnappauf G, Braus G, Lipscomb W N

机构信息

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA.

出版信息

Structure. 1997 Nov 15;5(11):1437-52. doi: 10.1016/s0969-2126(97)00294-3.

DOI:10.1016/s0969-2126(97)00294-3
PMID:9384560
Abstract

BACKGROUND

Chorismate mutase (CM) catalyzes the Claisen rearrangement of chorismate to prephenate, notably the only known enzymatically catalyzed pericyclic reaction in primary metabolism. Structures of the enzyme in complex with an endo-oxabicyclic transition state analogue inhibitor, previously determined for Bacillus subtilis and Escherichia coli CM, provide structural insight into the enzyme mechanism. In contrast to these bacterial CMs, yeast CM is allosterically regulated in two ways: activation by tryptophan and inhibition by tyrosine. Yeast CM exists in two allosteric states, R (active) and t (inactive).

RESULTS

We have determined crystal structures of wild-type yeast CM cocrystallized with tryptophan and an endo-oxabicyclic transition state analogue inhibitor, of wild-type yeast CM co-crystallized with tyrosine and the endo-oxabicyclic transition state analogue inhibitor and of the Thr226-->Ser mutant of yeast CM in complex with tryptophan. Binding of the transition state analogue inhibitor to CM keeps the enzyme in a 'super R' state, even if the inhibitory effector tyrosine is bound to the regulatory site.

CONCLUSIONS

The endo-oxabicyclic inhibitor binds to yeast CM in a similar way as it does to the distantly related CM from E. coli. The inhibitor-binding mode supports a mechanism by which polar sidechains of the enzyme bind the substrate in the pseudo-diaxial conformation, which is required for catalytic turnover. A lysine and a protonated glutamate sidechain have a critical role in the stabilization of the transition state of the pericyclic reaction. The allosteric transition from T-->R state is accompanied by a 15 degrees rotation of one of the two subunits relative to the other (where 0 degrees rotation defines the T state). This rotation causes conformational changes at the dimer interface which are transmitted to the active site. An allosteric pathway is proposed to include residues Phe28, Asp24 and Glu23, which move toward the activesite cavity in the T state. In the presence of the transition-state analogue a super R state is formed, which is characterised by a 22 degrees rotation of one subunit relative to the other.

摘要

背景

分支酸变位酶(CM)催化分支酸的克莱森重排反应生成预苯酸,这是初级代谢中唯一已知的酶促催化周环反应。先前已测定了与内型氧杂双环过渡态类似物抑制剂结合的枯草芽孢杆菌和大肠杆菌CM的结构,这些结构为该酶的作用机制提供了结构上的见解。与这些细菌CM不同,酵母CM受到两种方式的变构调节:色氨酸激活和酪氨酸抑制。酵母CM存在两种变构状态,即R(活性)态和T(非活性)态。

结果

我们测定了与色氨酸和内型氧杂双环过渡态类似物抑制剂共结晶的野生型酵母CM、与酪氨酸和内型氧杂双环过渡态类似物抑制剂共结晶的野生型酵母CM以及与色氨酸结合的酵母CM的Thr226→Ser突变体的晶体结构。即使抑制效应物酪氨酸结合到调节位点,过渡态类似物抑制剂与CM的结合也会使酶保持在“超R”状态。

结论

内型氧杂双环抑制剂与酵母CM的结合方式与其与大肠杆菌中亲缘关系较远的CM的结合方式相似。抑制剂的结合模式支持一种机制,即酶的极性侧链以假双轴构象结合底物,这是催化周转所必需的。赖氨酸和质子化的谷氨酸侧链在周环反应过渡态的稳定中起关键作用。从T态到R态的变构转变伴随着两个亚基之一相对于另一个亚基15度的旋转(其中0度旋转定义T态)。这种旋转导致二聚体界面处的构象变化,并传递到活性位点。提出了一条变构途径,包括在T态向活性位点腔移动的Phe28、Asp24和Glu23残基。在存在过渡态类似物的情况下,会形成超R态,其特征是一个亚基相对于另一个亚基旋转22度。

相似文献

1
Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.基于晶体结构的酵母分支酸变位酶的催化及别构调节机制
Structure. 1997 Nov 15;5(11):1437-52. doi: 10.1016/s0969-2126(97)00294-3.
2
The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and implications for the mechanism of the enzymatic reaction.来自枯草芽孢杆菌的单功能分支酸变位酶。分支酸变位酶及其与过渡态类似物和预苯酸复合物的结构测定,以及对酶促反应机制的启示。
J Mol Biol. 1994 Jul 29;240(5):476-500. doi: 10.1006/jmbi.1994.1462.
3
Structural evolution of differential amino acid effector regulation in plant chorismate mutases.植物分支酸变位酶中差异氨基酸效应物调控的结构演变
J Biol Chem. 2014 Oct 10;289(41):28619-28. doi: 10.1074/jbc.M114.591123. Epub 2014 Aug 26.
4
Electrostatic transition state stabilization rather than reactant destabilization provides the chemical basis for efficient chorismate mutase catalysis.静电过渡态稳定而非反应物去稳定化提供了高效分支酸变位酶催化的化学基础。
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17516-21. doi: 10.1073/pnas.1408512111. Epub 2014 Nov 24.
5
The near attack conformation approach to the study of the chorismate to prephenate reaction.用于研究分支酸向预苯酸反应的近攻击构象方法。
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12015-20. doi: 10.1073/pnas.1534873100. Epub 2003 Oct 1.
6
Crystal structure of the T state of allosteric yeast chorismate mutase and comparison with the R state.别构酵母分支酸变位酶T态的晶体结构及其与R态的比较。
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3330-4. doi: 10.1073/pnas.93.8.3330.
7
Energy and Enzyme Activity Landscapes of Yeast Chorismate Mutase at Cellular Concentrations of Allosteric Effectors.细胞浓度变构效应剂下酵母分支酸变位酶的能量和酶活性景观。
Biochemistry. 2019 Oct 1;58(39):4058-4069. doi: 10.1021/acs.biochem.9b00721. Epub 2019 Sep 20.
8
Comparison of formation of reactive conformers (NACs) for the Claisen rearrangement of chorismate to prephenate in water and in the E. coli mutase: the efficiency of the enzyme catalysis.在水中以及大肠杆菌变位酶中,分支酸经克莱森重排生成预苯酸的反应性构象体(NACs)形成的比较:酶催化的效率
J Am Chem Soc. 2003 May 14;125(19):5964-72. doi: 10.1021/ja0210648.
9
13C NMR studies of the enzyme-product complex of Bacillus subtilis chorismate mutase.枯草芽孢杆菌分支酸变位酶的酶-产物复合物的13C核磁共振研究。
Biochemistry. 1993 Apr 20;32(15):3965-72. doi: 10.1021/bi00066a017.
10
A tyrosine residue is involved in the allosteric binding of tryptophan to yeast chorismate mutase.一个酪氨酸残基参与色氨酸与酵母分支酸变位酶的变构结合。
Biochim Biophys Acta. 1993 Nov 10;1203(1):71-6. doi: 10.1016/0167-4838(93)90037-r.

引用本文的文献

1
(Reverse) Evolution of a Promiscuous Isochorismate Pyruvate Lyase into an Efficient Chorismate Mutase.一种杂乱的异分支酸丙酮酸裂解酶向高效分支酸变位酶的(反向)进化
Biochemistry. 2025 Aug 5;64(15):3459-3473. doi: 10.1021/acs.biochem.5c00157. Epub 2025 Jul 22.
2
Aromatic Amino Acids: Exploring Microalgae as a Potential Biofactory.芳香族氨基酸:探索微藻作为潜在生物工厂的可能性
BioTech (Basel). 2025 Jan 29;14(1):6. doi: 10.3390/biotech14010006.
3
Paradigms of convergent evolution in enzymes.酶的趋同进化模式。
FEBS J. 2025 Feb;292(3):537-555. doi: 10.1111/febs.17332. Epub 2024 Nov 22.
4
Mixed, nonclassical behavior in a classic allosteric protein.经典别构蛋白中的混合、非经典行为。
Proc Natl Acad Sci U S A. 2023 Sep 19;120(38):e2308338120. doi: 10.1073/pnas.2308338120. Epub 2023 Sep 11.
5
What Drives Chorismate Mutase to Top Performance? Insights from a Combined and Study.什么因素促使分支酸变位酶发挥出卓越性能?结合结构和动力学研究的深入了解。
Biochemistry. 2023 Feb 7;62(3):782-796. doi: 10.1021/acs.biochem.2c00635. Epub 2023 Jan 27.
6
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.变构作用:变构致癌驱动因子和创新变构药物。
J Mol Biol. 2022 Sep 15;434(17):167569. doi: 10.1016/j.jmb.2022.167569. Epub 2022 Apr 1.
7
Prediction of allosteric sites and signaling: Insights from benchmarking datasets.别构位点与信号传导的预测:来自基准数据集的见解
Patterns (N Y). 2021 Dec 9;3(1):100408. doi: 10.1016/j.patter.2021.100408. eCollection 2022 Jan 14.
8
Visualizing an Allosteric Intermediate Using CuAAC Stabilization of an NMR Mixed Labeled Dimer.利用 CuAAC 稳定 NMR 混合标记二聚体来可视化别构中间态。
ACS Chem Biol. 2021 Dec 17;16(12):2766-2775. doi: 10.1021/acschembio.1c00617. Epub 2021 Nov 16.
9
Molecular targets for antifungals in amino acid and protein biosynthetic pathways.氨基酸和蛋白质生物合成途径中抗真菌药物的分子靶标。
Amino Acids. 2021 Jul;53(7):961-991. doi: 10.1007/s00726-021-03007-6. Epub 2021 Jun 3.
10
Complete, closed and curated genome sequences of subsp. isolates from Australia indicate mobilome-driven localized evolution and novel pathogenicity determinants.来自澳大利亚的 亚种分离株的完整、封闭和精选基因组序列表明,可移动基因组驱动了局部进化和新的致病性决定因素。
Microb Genom. 2021 Apr;7(4). doi: 10.1099/mgen.0.000562.